SCHEMBL319961

SCHEMBL319961

O=C(O)Nc1csc(S(=O)(=O)c2cc(Cl)c(F)cc2F)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.38
ABL1 P00519 2/20 0.33
GPR27 Q9NS67 3/20 0.32
RORC P51449 1/20 0.32
PYGL P06737 1/20 0.31
PTPN22 Q9Y2R2 1/20 0.31
CA2 P00918 2/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CG P48736 1/20 0.31
PIK3C3 Q8NEB9 1/20 0.31
IDH1 O75874 1/20 0.31
SGK1 O00141 2/20 0.31
CDK5 Q00535 2/20 0.30
CDK5R1 Q15078 2/20 0.30
KCNQ3 O43525 1/20 0.30
KCNQ2 O43526 1/20 0.30
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30
CCNA1 P78396 1/20 0.30
CA1 P00915 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1745697 0.90 SLC1A3 (0.35) SMN1; SMN2CA2PIK3CDPIK3CGCDK5
SCHEMBL326998 0.74 PIK3CD (0.33) SMN1; SMN2GPR27PIK3CDPIK3CGPIK3C3
SCHEMBL29668968 0.74 CNR2 (0.32) SMN1; SMN2SGK1
SCHEMBL16094686 0.74 ALPL (0.35) ABL1
SCHEMBL27174917 0.72 PHGDH (0.38) RORCCA2CDK5CDK5R1CCNA2
SCHEMBL17675158 0.70 CA1 (0.41) SMN1; SMN2CA2PIK3CDPIK3CGCDK5
SCHEMBL1094850 0.63 PIK3CD (0.33) CA2PIK3CDPIK3CGCA1
SCHEMBL13646656 0.62 ALDH1A1 (0.33) PTPN22CA2SGK1CA1
SCHEMBL29641997 0.62 ALDH1A1 (0.33) PTPN22CA2SGK1CA1
SCHEMBL320178 0.61 SCN8A (0.36) PTPN22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590972-A2 CHEMICAL COMPOUNDS Pfizer Limited (GB) 2013-05-15 EP disclosed
WO-2012004706-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-12 WO disclosed